Use of all-transretinoic acid (ATRA) plus arsenic trioxide (ATO) to eliminate or minimize use of chemotherapy (CT) in untreated acute promyelocytic leukemia (APL) | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

2812051

Reference Type

Journal Article

Title

Use of all-transretinoic acid (ATRA) plus arsenic trioxide (ATO) to eliminate or minimize use of chemotherapy (CT) in untreated acute promyelocytic leukemia (APL)

Author(s)

Estey, EH; Garcia-Manero, G; Ferrajoli, A; Faderl, S; Verstovsek, S; Kantarjian, H

Year

2004

Is Peer Reviewed?

Yes

Journal

Blood
ISSN: 0006-4971
EISSN: 1528-0020

Volume

104

Issue

Page Numbers

115A-115A

Web of Science Id

WOS:000225127500396